Marker Therapeutics(MRKR) - 2019 Q3 - Earnings Call Transcript

Marker Therapeutics, Inc. (NASDAQ:MRKR) Q3 2019 Earnings Conference Call November 12, 2019 5:00 PM ET Company Participants Tony Kim – Chief Financial Officer Peter Hoang – President and Chief Executive Officer Mythili Koneru – Senior Vice President-Clinical Development Conference Call Participants Jackson Harvey – Nomura/Instinet Ted Tenthoff – Piper Jaffray Matt Biegler – Oppenheimer & Company Tony Butler – Roth Capital Yun Zhong – Janney Operator Greetings, and welcome to the Marker Therapeutics’ Third Qu ...